You are here Journals » Breast Cancer: Targets and Therapy » Volume 3

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer

Total article views   HTML views PDF downloads Totals
22,645 Dovepress* 12,600 3,881 16,481
PubMed Central* 10,045 522 10,567
Totals 22,645 4,403 27,048
*Since 26 August 2011
+Since July 2016

View citations on PubMed and Google Scholar